KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma

Histopathology, EarlyView.

Source: Histopathology - May 7, 2018 Category: Pathology Authors: Mitra Mehrad , Somak Roy , William A LaFramboise , Patti Petrosko , Caitlyn Miller , Pimpin Incharoen , Sanja Dacic Source Type: research